EUVIMEDEUVIMED entdecken
Crossref

FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy

Liqin Mu, Yu Zhao, Yang Li, Wei Gao, Jing Wang

Kidney Research and Clinical Practice · 20.08.2026

DOI: 10.23876/j.krcp.25.389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, online erschienen am 20.08.2026. Verfasst von Liqin Mu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, First Hospital of Hebei Medical University, Shijiazhuang, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Diabetic nephropathiesFOXO4 proteinHuman renal proximal tubular epithelial cell damageInflammationTissue-Factor-Pathway Inhibitor 2

Autor:innen und Institutionen

  • Department of General Medicine, First Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of General Medicine, First Hospital of Hebei Medical University, Shijiazhuang, China. wangjing2024q@163.com.

Zitieren

APA

Mu, L., Zhao, Y., Li, Y., Gao, W., & Wang, J. (2026). FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy. Kidney Research and Clinical Practice. https://doi.org/10.23876/j.krcp.25.389

Vancouver

Mu L, Zhao Y, Li Y, Gao W, Wang J. FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy. Kidney Research and Clinical Practice. 2026. doi:10.23876/j.krcp.25.389

BibTeX
@article{Mu2026,
  author = {Mu, Liqin and Zhao, Yu and Li, Yang and Gao, Wei and Wang, Jing},
  title = {FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy},
  journal = {Kidney Research and Clinical Practice},
  year = {2026},
  doi = {10.23876/j.krcp.25.389}
}
Kostenlos starten →